SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ACADIA Pharmaceuticals Inc (ACAD)
An SI Board Since April 2004
Posts SubjectMarks Bans Symbol
588 32 0 ACAD
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
513<Stuff continues to come out with Brann's name on it, though it's beeBiotech Jim-9/3/2008
512[Identification of novel selective V(2) receptor non-peptide agonists] >>tuck-9/3/2008
511Of course, I am not immediately further underwater...alas.mopgcw-8/25/2008
510Doubled down today at 2.45...now we wait.mopgcw-8/25/2008
509>> Anyone see an expected timeline for Allergan results << Glaucomascaram(o)uche-8/25/2008
508Give the recent weakness and news, I have had to take another hard look at this mopgcw-8/22/2008
507Citi:ACADIA Pharmaceuticals Inc (ACAD) 2Q:08 Results; Restructuring and Additionmopgcw-8/21/2008
506[Morphine desensitization, internalization and down-regulation of the mu opioid tuck-8/21/2008
505[Role of muscarinic receptors in the activity of N-desmethylclozapine: reversal tuck-8/13/2008
504[The role of M(1) muscarinic cholinergic receptors in the discriminative stimulutuck-8/9/2008
503Yes, a different story, at 2.30 and with a restructure, than when he wrote that scaram(o)uche-8/5/2008
502Yahoo's stats are likely stale, but even with a quarter's burn . . tuck-8/5/2008
501Another good call by AF. I agreed with him, and strangely still "got bit&qscaram(o)uche-8/5/2008
500>> having just bet that this CINN seller is one of the ride-alongs, pushinscaram(o)uche-8/5/2008
499:-) This one is going to have an interesting story behind it, no doubt. Bunch scaram(o)uche-8/1/2008
498>> Technically, a confirmed breakdown << Ya think? finance.yahoo.cscaram(o)uche-8/1/2008
497If it's Aberdeen, they sold their last share by or before their report date Ian@SI-8/1/2008
496Technically, a confirmed breakdown. Target in $2.70 area, in theory. Doesn'tuck-8/1/2008
495There have been "ride-along" shorts in on this decline. Hard to tell scaram(o)uche-8/1/2008
494[ERb-131: Differential modulation of inflammatory pain by a selective estrogen tuck-7/24/2008
493<i>an expanded list of authors' affiliations.....</i> Broad modscaram(o)uche-7/19/2008
492anybody see the blocks go by? no depth to bid or ask, hair trigger. maybe alsoscaram(o)uche-7/15/2008
491Interesting..... Tuck pointed to it the other day. I looked and got a little, scaram(o)uche-7/12/2008
490<b>Feuerstein's Biotech-Stock Mailbag: Acadia</b> thestreet.comidos-7/12/2008
489Neuropharmacology. 2008 Jun 7. [Epub ahead of print] Contextual renewal of nicoscaram(o)uche-7/6/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News